Another company has recalled another 19 lots of losartan tablets. Vivimed Life Sciences produced the medication and Heritage Pharmaceuticals distributed them. Investigators during routine testing discovered high levels of the carcinogen, NMBA. , have been recalled for exceeding the FDA allowable amount of NMBA.
About NMBA
NMBA (N-Nitroso N-Methyl 4-aminobutyric acid) is a chemical compound that studies have linked to cancer. PubChem showed NMBA exposure caused bladder cancer in rats. The levels FDA investigators discovered are less than the doses in the experiment. However, any dose could potentially cause cancer in humans. This is the second cancer threat. Recalls of losartan, valsartan, and irbesartan started in July 2018. Previously, the only carcinogen identified as NDEA.
New Losartan Lots Recalled
Vivimed Life Sciences removed 19 lots of losartan tablets. This also includes varying strengths of 25mg, 50mg, and 100mg in 90-count or 1,000-count bottles. It is recommended to save any recalled medication for testing. The NMBA recall began in March with Camber Pharmaceuticals and Torrent Pharmaceuticals. Hetero Labs Limited made its medication. Many stores like Walmart, Target, and Kroger distributed these medications.
Lot Numbers
| Product Name | Lot Number | Pack | Expiry Date | Distributed by |
|---|---|---|---|---|
| Losartan Potassium Tablets USP, 25 mg | CLO17006A | 90’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 50 mg | CLO17007A | 1000’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 50 mg | CLO17008A | 1000’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 50 mg | CLO17009A | 1000’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 50 mg | CLO17009B | 90’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 50 mg | CLO17010A | 90’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO17012A | 90’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO17013A | 90’s | Nov 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO17014A | 1000’s | Dec 2019 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO17015A | 1000’s | Jan 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO17016A | 1000’s | Jan 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO17017A | 1000’s | Jan 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO18001A | 1000’s | Jan 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO18002A | 90’s | Jan 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO18002B | 1000’s | Jan 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO18020A | 90’s | Apr 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO18021A | 90’s | Apr 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 100 mg | CLO18022A | 90’s | Apr 2020 | HERITAGE |
| Losartan Potassium Tablets USP, 50 mg | CLO18023A | 90’s | Apr 2020 | HERITAGE |
Seek Justice
Many people after taking losartan, valsartan or irbesartan medications are horrified to learn that their medication could have caused their liver cancer. Therefore, it is important to seek justice. These potentially cancer-causing drugs have been on the market for over 5 years. This is unacceptable. You should hold these manufacturers accountable.
We want to help send a message that this is not acceptable. If a dangerous product harmed you, we will be your advocate. Additionally, we have the experience necessary to successfully litigate these cases.
Contact the Michael Brady Lynch Firm today for a free consultation to learn more about seeking justice. A jury may award compensation for any medical expenses associated with this ordeal, as well as for your physical and emotional suffering. There is no obligation.